Latest news
BioMarin axes asset from $270M Inozyme takeover, ending run in rare metabolic indication - BioSpaceBioSpace · Mon, 10 Aug 2026 11:25:28 GMTBioMarin (BMRN) Is Up 6.3% After Raising 2026 Revenue Guidance And Highlighting Voxzogo Momentum - simplywall.stsimplywall.st · Sun, 09 Aug 2026 07:41:44 GMTBioMarin Pharmaceutical (0HNC) Q4 2025 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Sat, 08 Aug 2026 22:26:24 GMTBioMarin Pharmaceutical (0HNC) Q1 2025 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Sat, 08 Aug 2026 18:41:16 GMTBioMarin Pharmaceutical (0HNC) Q3 2025 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Sat, 08 Aug 2026 17:58:15 GMTBioMarin Pharmaceutical (0HNC) Q2 2025 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Sat, 08 Aug 2026 17:56:56 GMTBioMarin Pharmaceutical (0HNC) Q4 2024 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Sat, 08 Aug 2026 17:54:18 GMTBioMarin Pharmaceutical (0HNC) Q1 2026 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Sat, 08 Aug 2026 13:55:35 GMT